Research
What a state sterile compounding license adds
In California, a pharmacy that compounds sterile preparations holds a second license on top of its pharmacy license, and that second one cannot be issued until an inspector has been inside the room.
A second license stacked on the first
California requires a pharmacy license for each premises, renewed annually. Sterile compounding is regulated on top of that, in a separate article of the same pharmacy chapter.
The rule is stated as a prohibition rather than a permission. A pharmacy shall not compound sterile drug products unless the pharmacy has obtained a sterile compounding pharmacy license from the board, and that license is renewed annually and is not transferable.
The license is also anchored to the underlying pharmacy in two ways at once. It is issued only to a location that is licensed as a pharmacy, and only to the owner of the pharmacy licensed at that location.
That construction means the sterile license cannot travel. It is not a credential a company carries between sites or a certification an owner keeps through a sale, because it names both a licensed address and the owner of the license at that address.
The consequence for anyone reading a pharmacy's credentials is that a general California pharmacy license is not evidence of sterile compounding authority. They are separate records, and the second one either exists for that address or it does not.
What has to happen before it issues
The inspection requirement is unconditional in both directions. The license shall not be issued or renewed until the location is inspected by the board and found in compliance with the article and the regulations the board has adopted.
On top of the inspection, the statute lists what the board must do before issuing or renewing, and it is a document review rather than a site visit. The board reviews a current copy of the pharmacy's policies and procedures for sterile compounding.
The board also reviews the pharmacy's completed self-assessment form required by the board's own regulation, which makes the pharmacy's own account of its practice part of the licensing file rather than something held internally.
The board must be provided with copies of all inspection reports conducted of the pharmacy's premises, and any reports from a private accrediting agency, conducted in the prior twelve months and documenting the pharmacy's operations. A private accreditation report is therefore not an alternative to state review in California; it is an input the state reviewer is entitled to see.
Finally, the board receives a list of all sterile medications compounded by the pharmacy since the last license renewal. The state's file includes what was actually made, not only what the pharmacy is equipped to make.
The out-of-state version, and who pays for the inspection
California applies a parallel license to pharmacies compounding sterile preparations elsewhere and shipping them in. A nonresident pharmacy shall not compound sterile drug products for shipment into the state without a sterile compounding pharmacy license issued by the board, renewed annually and not transferable.
It is anchored the same way: issued only to a location licensed as a nonresident pharmacy, and only to the owner of the nonresident pharmacy licensed at that location.
The inspection language is where the out-of-state version differs. The license shall not be issued or renewed until the location is inspected by the board and found in compliance, and the nonresident pharmacy shall reimburse the board for all actual and necessary costs incurred by the board in conducting an inspection of the pharmacy at least once annually.
That is a state regulator traveling to another state, annually, at the licensee's expense. It is a materially different posture from accepting a home-state inspection report, which is how the same state handles ordinary nonresident pharmacy licensure.
The pre-issuance document review mirrors the in-state list, with one change of scope: the board receives a list of all sterile drug products compounded by the pharmacy within the prior twelve months, rather than since the last renewal.
The carve-out for reconstitution
The statute contains a narrow exception that is easy to over-read, so its two conditions are worth stating exactly.
The reconstitution of a sterile powder does not require a sterile compounding license if both of the following are met: the sterile powder was obtained from a manufacturer, and the drug is reconstituted for administration to patients by a health care professional licensed to administer drugs by injection under that division of the code.
Both limbs are load-bearing. The powder has to have come from a manufacturer, and the reconstitution has to be for administration by a licensed professional, not for supply.
Nothing in the exception addresses powders that did not come from a manufacturer, or reconstitution done for any purpose other than administration by such a professional. The section simply does not reach those cases, and an exception that does not reach a case is not permission for it.
This is the clearest illustration in the article of why a license question and a product question are different. Whether an activity needs the license is settled by the statute; whether a particular preparation was made properly is settled by records the statute does not itself produce.
Outsourcing facilities get their own state license
The third layer in California is the outsourcing facility, and the statute is explicit that federal registration is not the whole story.
An outsourcing facility that is licensed with the federal Food and Drug Administration and has an address in the state shall also be licensed by the board as an outsourcing facility before doing business within the state. That license is renewed annually and is not transferable.
The substantive standard is doubled as well. An outsourcing facility shall compound all sterile products and nonsterile products in compliance with regulations issued by the board and with federal current good manufacturing practices applicable to outsourcing facilities.
The pre-issuance review is broader than the pharmacy version. Before inspection the board reviews a current copy of the facility's policies and procedures for sterile and nonsterile compounding; it is provided with copies of all federal and state regulatory agency inspection reports, as well as accreditation reports and certification reports of facilities or equipment, conducted in the prior twelve months; and it receives a list of all sterile and nonsterile drugs compounded as reported to the federal agency in the last twelve months.
That last item is the most quietly significant. The state's file is built partly from what the facility already told the federal agency, which means the two regulators are reading the same production list rather than separate accounts of it.
Key takeaways
- California requires a separate sterile compounding license on top of the pharmacy license for that address.
- The sterile license is issued only to an already licensed location and only to that location's license owner.
- It cannot be issued or renewed until a board inspection finds the location in compliance.
- Private accreditation reports are an input the board must be given, not a substitute for state inspection.
- A nonresident compounder shipping into California reimburses the board for at least one inspection a year.
- California requires a state outsourcing facility license in addition to the federal registration for an in-state address.
Frequently asked questions
Is a California pharmacy license enough to compound sterile preparations?
No. California states that a pharmacy shall not compound sterile drug products unless it has obtained a sterile compounding pharmacy license from the board, renewed annually and not transferable. That license is issued only to a location already licensed as a pharmacy and only to the owner of the pharmacy licensed at that location. A general pharmacy license and a sterile compounding license are separate records for the same address.
Does the state have to inspect before the license issues?
Yes, and before each renewal. The California section states that a license to compound sterile drug products shall not be issued or renewed until the location is inspected by the board and found in compliance with the article and the regulations the board has adopted. The inspection sits alongside a document review that includes the pharmacy's sterile compounding policies and procedures and its completed self-assessment form.
Does private accreditation substitute for state review in California?
The statute treats accreditation as an input rather than a substitute. Before issuing or renewing, the board must be provided with copies of all inspection reports conducted of the pharmacy's premises and any reports from a private accrediting agency conducted in the prior twelve months documenting the pharmacy's operations. The accreditor's findings go into the state file; they do not replace the state inspection the same section requires.
How does California handle a compounder in another state?
With a parallel nonresident sterile compounding license, which a nonresident pharmacy must hold before compounding sterile drug products for shipment into the state. The license shall not be issued or renewed until the board inspects the location, and the nonresident pharmacy must reimburse the board for all actual and necessary costs of conducting an inspection at least once annually.
Is reconstituting a powder the same as compounding for this purpose?
California carves it out only under two conditions read together. The reconstitution of a sterile powder does not require the license if the sterile powder was obtained from a manufacturer and the drug is reconstituted for administration to patients by a health care professional licensed to administer drugs by injection. Cases outside those two conditions are simply not addressed by the exception.
What does a state outsourcing facility license add to the federal registration?
California requires an outsourcing facility licensed with the federal agency and holding an address in the state to also be licensed by the board before doing business in the state, and to compound all sterile and nonsterile products in compliance with board regulations and with federal current good manufacturing practices applicable to outsourcing facilities. Before inspection, the board receives the facility's federal and state inspection reports and a list of everything it compounded as reported to the federal agency in the last twelve months.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- California Business and Professions Code section 4127.1, sterile compounding pharmacy license, pre-issuance review and the reconstitution exception
- California Business and Professions Code section 4127.2, sterile compounding license for nonresident pharmacies shipping into the state, and the annual inspection reimbursed by the licensee
- California Business and Professions Code section 4129.1, state licensure of outsourcing facilities in addition to federal registration
- California Business and Professions Code section 4110, requiring a board license for each pharmacy premises and annual renewal